Printer Friendly

Browse Infection topic

Drug therapy subtopic

Articles

1-300 out of 319 article(s) nextnext page
Title Author Type Date Words
First Patient Dosed in Phase 1 Study of VNRX-9945 for the Treatment of Chronic Hepatitis B Virus Infection. Jun 30, 2021 348
Uganda approves use of herbal medicine to treat viral infections. Jun 29, 2021 356
FDA approves ibrexafungerp for vaginal yeast infection. Frellick, Marcia Jun 1, 2021 415
Review of Pharmacotherapy Trialed for Management of the Coronavirus Disease-19. Hall, Kimberly; Mfone, Fuhbe; Shallcross, Michael; Pathak, Vikas Jun 1, 2021 6616
Qpex Biopharma Initiates Phase 1 Study of ORAvance for Oral Treatment of Drug-Resistant Gram-Negative Bacterial Infections. Drug overview May 12, 2021 448
Oral drug successfully treats SARS-CoV-2 infections in hamsters. Apr 23, 2021 323
Genotypic Characterisation of Multi Drug Resistant Gram-Negative Bacteria with Special Reference to Carbapenem Resistance in a Teaching Hospital, Hyderabad, Telangana State. Gurajala, Swathi; Tipparthi, Sandeep Kumar; H.r.v., Rajkumar Apr 5, 2021 1840
First Human Subject Dosed in a Phase I Clinical Trial of ALS-4, a First-in-Class Small Molecule Drug Designed to Treat Infections caused by Staphylococcus Aureus including Methicillin-resistant Staphylococcus aureus. Apr 1, 2021 269
Dapsone as an Effective Treatment for Arthritis Secondary to Hidradenitis Suppurativa. Timofte, Irina; Smith, Howard Disease/Disorder overview Apr 1, 2021 1961
Challenges of Antiretroviral Treatment for Human Immunodeficiency Virus Infection in Pakistan. Shah, Sharaf Ali; Altaf, Arshad; Vermund, Sten H. Report Mar 31, 2021 1817
US FDA Approves Kimyrsa for the Treatment of Adult Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI). Mar 16, 2021 651
Corticosteroid-responsive Epilepsia Partialis Continua/Kortikosteroide Yanitli Epilepsiya Parsiyalis Kontinua. Kalita, Jayantee; Pandey, Prakash Chandra; Chaudhary, Sarvesh Kumar; Singh, Varun Kumar; Misra, Usha Clinical report Mar 1, 2021 2613
Intravenous drug abusers presenting with pseudoaneurysm and other surgical complications in Pakistan. Qudeer, Muhammad Amar; Naqi, Syed Asghar; Sarwar, , Muhammad Zeeshan; Mujahid, Hafiza Amina Report Feb 28, 2021 1676
Revelation Biosciences Approved to Initiate a Multiple Dose Cohort to Phase 1 Clinical Study of Experimental Treatment for Respiratory Viral Infection, Including COVID-19. Feb 3, 2021 670
Entecavir and Tenofovir Treatment in Patients With Hepatitis B Virus-Related Cirrhosis: A Comparison of Results of Two-Year Treatment/Hepatit B Virusuyla Iliskili Sirozu Olan Hastalarda Entekavir ve Tenofovir Tedavisi: Iki Yillik Tedavi Sonuclarinin Karsilastirilmasi. Alkan, Erhan; Akin, Mete; Tuna, Yasar Dec 1, 2020 3629
Antibiotic awareness week. Nov 25, 2020 597
TrippBio Touts Positive Results from Investigator-Initiated Clinical Trial of TD213 for the Treatment of Mild to Moderate COVID-19 Infections. Nov 17, 2020 295
Revelation Biosciences Starts a Phase 1 Clinical Study for REVTx 99 Experimental Treatment for Respiratory Viral Infection, Including COVID 19. Nov 16, 2020 553
Efficacy of Double-Dose Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome (PTLDS) and Associated Co-infections: A Report of Three Cases and Retrospective Chart Review. Horowitz, Richard I.; Freeman, Phyllis R. Report Nov 1, 2020 16382
Antimicrobial and Antibiofilm Activities of Essential Oils against Escherichia coli O157:H7 and Methicillin-Resistant Staphylococcus aureus (MRSA). Gomez-Sequeda, Nicolas; Caceres, Marlon; Stashenko, Elena E.; Hidalgo, William; Ortiz, Claudia Nov 1, 2020 9856
Adjunctive Use of Phage Sb-1 in Antibiotics Enhances Inhibitory Biofilm Growth Activity versus Rifampin-Resistant Staphylococcus aureus Strains. Wang, Lei; Tkhilaishvili, Tamta; Trampuz, Andrej Nov 1, 2020 5702
The Safety and Efficacy of Phage Therapy for Superficial Bacterial Infections: A Systematic Review. Steele, Angharad; Stacey, Helen J.; de Soir, Steven; Jones, Joshua D. Nov 1, 2020 8398
The Safety and Efficacy of Phage Therapy for Bone and Joint Infections: A Systematic Review. Clarke, Alex L.; de Soir, Steven; Jones, Joshua D. Nov 1, 2020 6259
Antimicrobial and Antibiofilm Capacity of Chitosan Nanoparticles against Wild Type Strain of Pseudomonas sp. Isolated from Milk of Cows Diagnosed with Bovine Mastitis. Aguayo, Paula Rivera; Larenas, Tamara Bruna; Godoy, Carlos Alarcon; Rivas, Bernardita Cayupe; Gonzal Report Sep 1, 2020 7529
A Localized Phage-Based Antimicrobial System: Effect of Alginate on Phage Desorption from [beta]-TCP Ceramic Bone Substitutes. Ismail, Rached; Carareto, Natalia D. Dorighello; Hornez, Jean-Christophe; Bouchart, Franck Report Sep 1, 2020 5148
Ibrexafungerp: A Novel Oral Triterpenoid Antifungal in Development for the Treatment of Candida auris Infections. Ghannoum, Mahmoud; Arendrup, Maiken Cavling; Chaturvedi, Vishnu P.; Lockhart, Shawn R.; McCormick, T Report Sep 1, 2020 6911
Evaluation of Resistance in Staphylococcus aureus Strains Isolated From Blood Cultures to Methicillin and Other Antimicrobial Agents/Kan Kulturlerinden Izole Edilen Staphylococcus aureus Suslarinin Metisiline ve Diger Antimikrobiyal Ajanlara Direnc Durumlarinin Degerlendirilmesi. Kula-Atik, Tugba; Uzun, Berrin Report Aug 1, 2020 2753
A Hundred Years of Bacteriophages: Can Phages Replace Antibiotics in Agriculture and Aquaculture? Sieiro, Carmen; Areal-Hermida, Lara; Pichardo-Gallardo, Angeles; Almuina-Gonzalez, Raquel; de Miguel Aug 1, 2020 13962
The Ascidian-Derived Metabolites with Antimicrobial Properties. Casertano, Marcello; Menna, Marialuisa; Imperatore, Concetta Aug 1, 2020 15458
Coronavirus: Arthritis drug could be used to treat Covid-19, scientists say; Researchers from Imperial College London say that a drug called tocilizumab could treat Covid-19 by halting the immune system 'storm' that the body produces in response to infection. By, Shivali Best Jul 28, 2020 258
Can antibiotics treat COVID-19 (coronavirus) and other treatments. Jul 4, 2020 228
Calcineurin inhibitors revisited: A new paradigm for COVID-19? Hage, Rene; Steinack, Carolin; Schuurmans, Mace M. Report Jul 1, 2020 1522
EMD Serono Initiates First Clinical Trial of TLR7 and 8 Inhibitor as a Potential Treatment for Severe Symptoms of Covid-19 Infection. Jun 26, 2020 580
WHO: Concerns as bacterial infections become drug resistant. Jun 3, 2020 451
The Revaluation of Plant-Derived Terpenes to Fight Antibiotic-Resistant Infections. Cappiello, Floriana; Loffredo, Maria Rosa; Del Plato, Cristina; Cammarone, Silvia; Casciaro, Bruno; Report Jun 1, 2020 13699
Malaria Parasite Density as a Predictor of Hematological Parameter Changes among HIV Infected Adults Attending Two Antiretroviral Treatment Clinics in Kano, Northwest Nigeria. Jegede, Feyisayo E.; Oyeyi, Tinuade I.; Abdulrahman, Surajudeen A.; Mbah, Henry A. May 31, 2020 7200
Chitosan-Based Nanoparticles for Intracellular Delivery of ISAV Fusion Protein cDNA into Melanoma Cells: A Path to Develop Oncolytic Anticancer Therapies. Robles-Planells, Claudia; Sanchez-Guerrero, Giselle; Barrera-Avalos, Carlos; Matiacevich, Silvia; Ro May 31, 2020 6711
PureTech Advances LYT-100 for Treatment of Serious Respiratory Complications that Persist Following Resolution of COVID-19 Infection. Disease/Disorder overview May 28, 2020 693
High Primary Antibiotic Resistance of Helicobacter pylori Strains Isolated from Pediatric and Adult Patients in Poland during 2016-2018. Krzyzek, Pawel; Pawelka, Dorota; Iwanczak, Barbara; Kempinski, Radoslaw; Lesniakowski, Konrad; Megra Report May 1, 2020 3788
Antimicrobial Efficacy of Five Probiotic Strains Against Helicobacter pylori. Saracino, Ilaria Maria; Pavoni, Matteo; Saccomanno, Laura; Fiorini, Giulia; Pesci, Valeria; Foschi, May 1, 2020 4832
Biohaven Pharma's Phase 2 lung infection candidate trial approved by FDA. Apr 9, 2020 191
Pan-Drug Resistant Acinetobacter baumannii, but Not Other Strains, Are Resistant to the Bee Venom Peptide Melittin. Rangel, Karyne; Lechuga, Guilherme Curty; Souza, Andre Luis Almeida; Carvalho, Joao Pedro Rangel da Report Apr 1, 2020 6454
INJUDICIOUS USE OF ANTIBIOTICS IN ENDODONTICS; A CROSS SECTIONAL STUDY. MOHIB ULLAH, AJMAL YOUSAF, MAFAZA ALAM, FATIMA ALI, ALI AKHTAR KHAN AND LAILA SHAH KHAN Mar 31, 2020 2280
Old and Recent Advances in Life Cycle, Pathogenesis, Diagnosis, Prevention, and Treatment of Malaria Including Perspectives in Ethiopia. Nureye, Dejen; Assefa, Solomon Mar 31, 2020 13765
FDA Clears First Clinical Study for a Polymicrobial Phage Library-Based Treatment for Antibiotic-Resistant Infections. Clinical report Mar 18, 2020 710
DRUG TO STOP HIV ON NHS; Plan to eliminate infections by 2030. HELEN WILLIAMS Mar 16, 2020 256
DRUG TO STOP HIV ON NHS; Plan to eliminate infections by 2030. HELEN WILLIAMS Mar 16, 2020 258
M Health Fairview: Leaders at the University of Minnesota Health and Fairview Health Services, together with researchers from Amgen, have collaborated to create a framework for better predicting the potential for severe infection among chemotherapy patients. Hagland, Mark Mar 1, 2020 1392
Prevalence of asymptomatic malaria in HIV-infected subjects on cotrimoxazole antimalarial prophylaxis attending a tertiary health care center in southern Nigeria: a cross-sectional study. Ekere, Ekerette Friday; Mirabeau, Tatfeng Youtchou; Okoroiwu, Henshaw Uchechi Report Mar 1, 2020 3769
Real-life experience of ledipasvir and sofosbuvir singletablet regimen among chronic hepatitis C patients in Turkey. Yamazhan, Tansu; Turan, Ilker; Ersoz, Galip; Gunsar, Fulya; Pullukcu, Husnu; Danis, Nilay; Unal, Nal Mar 1, 2020 4151
Real-life experience of ledipasvir and sofosbuvir single-tablet regimen among chronic hepatitis C patients in Turkey. Yamazhan, Tansu; Turan, Ilker; Ersoz, Galip; Gunsar, Fulya; Pullukcu, Husnu; Danis, Nilay; Unal, Nal Mar 1, 2020 4377
Intravenous Ceftriaxone Versus Multiple Dosing Regimes of Intravenous Anti-Staphylococcal Antibiotics for Methicillin-Susceptible Staphylococcus aureus (MSSA): A Systematic Review. Kamfose, Musaiwale M.; Muriithi, Francis G.; Knight, Thomas; Lasserson, Daniel; Hayward, Gail Report Feb 1, 2020 5149
PhagoMed looks to raise around $18M to scale up its bacterial infections treatment. Jan 14, 2020 120
FDA approves Tula system for recurrent pediatric ear infections. Palmer, Christopher Jan 1, 2020 232
Treatment of chronic hepatitis C in patients with chronic kidney disease with Sofosbuvir-basead regimes. Rossato, Giovana; Tovo, Cristiane Valle; Almeida, Paulo Roberto Lerias de Jan 1, 2020 3004
Investigating the Effect of Prompt Treatment on Malaria Prevalence in Children Aged below Five Years in Zambia: A Nested Case-Control Study in a Cross-Sectional Survey. Nawa, Mukumbuta Survey Jan 1, 2020 5674
Impact of Treatment with Direct Acting Antiviral Drugs on Glycemic Control in Patients with Hepatitis C and Diabetes Mellitus. Mada, Pradeep Kumar; Malus, Matthew E.; Parvathaneni, Arvin; Chen, Bing; Castano, Gabriel; Adley, Sh Jan 1, 2020 4273
Inhibition of the Nrf2-TrxR Axis Sensitizes the Drug-Resistant Chronic Myelogenous Leukemia Cell Line K562/G01 to Imatinib Treatments. Xu, Lianrong; Zhao, Yan; Pan, Fei; Zhu, Mengxia; Yao, Liqin; Liu, Yan; Feng, Jiangfang; Xiong, Jie; Dec 31, 2019 7166
Frequency and antibiogram of multi-drug resistant pseudomonas aeruginosa in a Tertiary Care Hospital of Pakistan. Lubna Farooq, Zahida Memon, Muhammad Owais Ismail and Sara Sadiq Dec 31, 2019 3196
RedHill Biopharma Initiates U.S. Promotion of Aemcolo[R] for Travelers' Diarrhea. Dec 17, 2019 2465
Clinical Spectrum and Treatment Outcomes of HIV Associated Cancers in a Tertiary Care Centre. Elumalai, Senthilkumar; Kannan, Kalaichelvi; Sundarrajan, Sureshkumar; Gopal, Raja Report Dec 16, 2019 2551
Vital Signs: Status of Human Immunodeficiency Virus Testing, Viral Suppression, and HIV Preexposure Prophylaxis--United States, 2013-2018. Harris, Norma S.; Johnson, Anna Satcher; Huang, Ya-Lin A.; Kern, Dayle; Fulton, Paul; Smith, Dawn K. Dec 6, 2019 5040
When guideline treatment of asthma fails, consider a macrolide antibiotic: This class of drugs has the potential to benefit patients with persistent, poorly controlled asthma and those with new-onset disease as an adjunct to first-line therapy. Hahn, David L. Dec 1, 2019 5441
Biliary Tract Infections: Causative Agents and Analysis of Risk Factors for Infections With Drug-Resistant Bacteria/ Safra Yolu Infeksiyonlarinin Etkenleri ve Antibiyotige Direncli Bakteri Infeksiyonlari Icin Risk Faktorlerinin Analizi. Basaran, Seniha; Ozsut, Halit; Cagatay, Atahan; Eraksoy, Haluk Dec 1, 2019 3655
Systematic Review with Meta-Analysis: Efficacy and Safety of Direct-Acting Antivirals for Chronic Hepatitis C Genotypes 5 and 6. Due, Ong The; Chaikledkaew, Usa; Genuino, Anne Julienne M.; Sobhonslidsuk, Abhasnee; Thakkinstian, A Nov 30, 2019 9286
RedHill Biopharma Announces FDA Approval of Talicia[R] for Treatment of H. pylori in Adults. Nov 4, 2019 3113
Acute Upper Respiratory Infections Study: A study looked at the addition of a herpes medicine. Nov 1, 2019 261
Hemophagocytic Lymphohistiocytosis in an AIDS Patient with Kaposi Sarcoma: A Treatment Dilemma. Emiloju, Oluwadunni E.; Gupta, Sorab; Arguello-Guerra, Vivian; Dourado, Claudia Oct 31, 2019 2605
Gilead Sciences (NASDAQ: GILD) - U.S. Food and Drug Administration Approves Descovy[R] for HIV Pre-Exposure Prophylaxis (PrEP) -- 3/10/2019. Oct 9, 2019 799
Unmet Need for Contraception among HIV-Positive Women Attending HIV Care and Treatment Service at Saint Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia. Abubeker, Ferid A.; Fanta, Malede B.; Dalton, Vanessa K. Sep 30, 2019 4216
Clinical Profile and its Relationship with CD4+ Count in Treatment Naive HIV Infected Subjects. Javaid M.I., Iqbal H.M.N., Ghazanfar M., Haider S., Mazhar S., Natiq M., Ahmad R. and Anwar A. Sep 30, 2019 3777
Guideline Updated for Prevention, Management of Hep C in CKD; 32 key recommendations focus on prevention, diagnosis, treatment, management of hepatitis C virus. Sep 23, 2019 260
HBsAg, Anti-HCV and Anti-HIV Seroprevalance Among Drug Users: a Retrospective Assessment. Altuglu, Imre; Tanyeri, Selin; Zeytinoglu, Aysin; Altintoprak, Ayse Ender Clinical report Sep 1, 2019 3991
Procalcitonin testing as an aid to antibiotic stewardship. Levy, H. Roma; Sayegh, Monet Sep 1, 2019 4497
Zika Virus Infection Drug Market Growth, Type, Route of Administration, Analysis 2019 - Valneva SE, Moderna, Inc, Novavax, Inc, Johnson & Johnson Services, Inc, Themis Bioscience GmbH, Sanofi, IMV Inc. Aug 29, 2019 951
FDA's CRL to Sarepta's golodirsen citing risk of infection, renal toxicity. Aug 19, 2019 213
Fact.MR Releases New Report on the Amoxicillin Drugs Market 2018-2028. Aug 9, 2019 1009
The cornerstone of effective stewardship is in the microbiology lab. Ginocchio, Christine Aug 1, 2019 2829
Efficacy of Routine Fecal Microbiota Transplantation for Treatment of Recurrent Clostridium difficile Infection: A Retrospective Cohort Study. Nowak, Alexandra; Hedenstierna, Magnus; Ursing, Johan; Lidman, Christer; Nowak, Piotr Report Jul 31, 2019 4412
Progress in Testing for and Treatment of Hepatitis C Virus Infection Among Persons Who Inject Drugs--Georgia, 2018. Stvilia, Ketevan; Spradling, Philip R.; Asatiani, Alexander; Gogia, Maka; Kutateladze, Khatuna; Buts Jul 26, 2019 2220
US HHS, DoD and VenatoRx Pharmaceuticals to co-develop novel antibiotic for treatment of drug-resistant infections. Jul 23, 2019 334
US HHS, DoD and VenatoRx Pharmaceuticals to co-develop novel antibiotic for treatment of drug-resistant infections. Jul 23, 2019 330
Drug addicts, tansgenders are the main source of HIV in Pakistan, official says. Jul 14, 2019 862
Drug addicts, transgenders are the main source of HIV in Pakistan, official says. Jul 14, 2019 913
Amoxicillin Drugs Market Scenario Indicates Prime Trends & Growth Parameters, 2018-2028. Jul 3, 2019 805
Amoxicillin Drugs Market Progress & Manufacturer Contribution Highlighted until 2028. Jul 3, 2019 790
Treatment Outcomes of Hepatitis C-Infected Patients in Specialty Clinic vs. Primary Care Physician Clinic: A Comparative Analysis. Syed, Taseen Ahmed; Bashir, Muhammad Hassaan; Farooqui, Samid Muhammad; Chen, Allshine; Chen, Sixia; Jun 30, 2019 4714
How to incorporate HIV PrEP into your practice: These recommendations and resources can help make HIV pre-exposure prophylaxis an essential part of your work. Stewart, Jenell; Stekler, Joanne D. Jun 1, 2019 4310
Prevalence and Reinfection Rates of Schistosoma mansoni and Praziquantel Efficacy against the Parasite among Primary School Children in Sanja Town, Northwest Ethiopia. Woldegerima, Eden; Bayih, Abebe Genetu; Tegegne, Yalewayker; Aemero, Mulugeta; Zeleke, Ayalew Jejaw Report May 31, 2019 4649
Drug-resistant fungal infections could be treated by starving fungus: Study. May 25, 2019 468
RedHill Biopharma submits NDA to FDA for Talicia for H. pylori Infection. May 7, 2019 123
New findings could lead to better detection, treatment of chronic malaria. Clinical report May 3, 2019 540
FDA approves Sanofi's Dengvaxia for the prevention of a mosquito-borne viral disease. Vecchione, Anthony May 2, 2019 523
Life-threatening Listeria meningitis: Need for revision of South African acute bacterial meningitis treatment guidelines. Schutte, C.M.; van der Meyden, C.H.; Kakaza, M.; Lockhat, Z.; van der Walt, E. Report May 1, 2019 2340
Prevalence of human immunodeficiency virus and Hepatitis (B and C) among drug users in a tertiary care public hospital. Apr 30, 2019 3147
Gilead Sciences (NASDAQ: GILD) - Gilead Submits Supplemental New Drug Application to U.S. Food and Drug Administration for Once-Daily Descovy[R] for HIV Pre-Exposure Prophylaxis -- 5/4/2019. Apr 11, 2019 2345
The US FDA announces approval of first two-drug complete regimen for HIV-infected patients. Apr 9, 2019 248
The US FDA announces approval of first two-drug complete regimen for HIV-infected patients. Apr 9, 2019 244
Comparison of Antiretroviral Therapy Regimens With Regard to Virological and Immunological Response in Treatment-Naive HIV/AIDS Patients/Tedavi Naif HIV/AIDS Hastalarinda Kullanilan Antiretroviral Tedavi Rejimlerinin Virolojik ve Immunolojik Yanit Acisindan Karsilastirilmasi. Akkaya-Isik, Sinem; Gunduz, Alper; Oncul, Ahsen; Hamidi, Aziz Ahmad; Yildiz-Sevgi, Dilek; Kes-Uzun, Report Apr 1, 2019 4233
Stenotrophomonas maltophilia: Results of Antimicrobial Susceptibility Testing and In Vitro Activity of the Combination of Ceftazidime and Moxifloxacin/Stenotrophomonas maltophilia: Antimikrobik Duyarlilik Testi Sonuclari ve Seftazidimin Moksifloksasinle Kombinasyonunun In Vitro Etkinligi. Sadic, Betul; Basaran, Seniha; Simsek-Yavuz, Serap; Cagatay, Atahan; Ozsut, Halit; Eraksoy, Haluk Report Apr 1, 2019 3294
EFFECTIVENESS AND SAFETY OF SOFOSBUVIR AND DACLATASVIR COMBINATION FOR THE TREATMENT OF HEPATITIS C. Mar 31, 2019 2133
Mathematical Analysis of a Mathematical Model of Chemovirotherapy: Effect of Drug Infusion Method. Malinzi, Joseph Mar 31, 2019 9194
Primary HIV Drug Resistance among Recently Infected Cases of HIV in North-West India. Chauhan, C.K.; Lakshmi, P.V.M.; Sagar, V.; Sharma, A.; Arora, S.K.; Kumar, R. Mar 31, 2019 4538
HIV Diagnoses Among Persons Who Inject Drugs--Northeastern Massachusetts, 2015-2018. Cranston, Kevin; Alpren, Charles; John, Betsey; Dawson, Erica; Roosevelt, Kathleen; Burrage, Amanda; Mar 15, 2019 1225
Finch Therapeutics' Investigational Drug CP101 Granted Breakthrough Therapy Designation from FDA for Recurrent C. Difficile Infection. Feb 8, 2019 433
Researchers find new treatment for Chlamydia. Feb 6, 2019 418
Prescription of Antibacterial Drugs for HIV-Exposed, Uninfected Infants, Malawi, 2004-2010. Ewing, Alexander C.; Davis, Nicole L.; Kayira, Dumbani; Hosseinipour, Mina C.; van der Horst, Charle Report Jan 1, 2019 7910
In vitro Susceptibility of Pseudomonas aeruginosa Isolated from Acute and Chronic Pulmonary Infection to Antibiotics, Lactobacillus Competition and Metal Nanoparticles. Rehman, Safia; Ali, Nazish Mazhar; Pier, Gerald B.; Liaqat, Iram; Mazhar, Bushra Clinical report Dec 31, 2018 4646
Antibiotics advice for the winter; IN BRIEF. Nov 21, 2018 185
MYR Pharma receives US FDA breakthrough therapy designation for Myrcludex to treat chronic Hepatitis B and D infections. Oct 24, 2018 174
MYR Pharma receives US FDA breakthrough therapy designation for Myrcludex to treat chronic Hepatitis B and D infections. Oct 24, 2018 178
Rising threat of resistance to drugs. Oct 2, 2018 829
Overuse of antibiotics could endanger lives, medical experts warn. Oct 1, 2018 645
Cidara Therapeutics Initiates Phase 3 Trial of Lead Antifungal Rezafungin for Treatment of Invasive Candida Infections. Sep 28, 2018 493
Topical Antibiotic Pharmaceuticals Market to Actively Foray into Emerging Consumer Market places Dur. Sep 27, 2018 397
FDA: Common Diabetes Meds Tied to Serious Genital Infection; Sodium-glucose cotransporter-2 inhibitors linked to 12 cases of Fournier's gangrene. Aug 30, 2018 272
AIDS drugs show more promise for preventing new infections. Jul 24, 2018 694
Effectiveness of chronic hepatitis C treatment with direct-acting antivirals in the Public Health System in Brazil. Holzmann, Iandra; Tovo, Cristiane V.; Minme, Roseline; Leal, Monica P.; Kliemann, Michele P.; Ubiraj Report Jul 1, 2018 4199
PREVALENCE OF FAILURE OF FIRST-LINE ANTIRETROVIRAL THERAPY--STUDY AT RIMS, A TERTIARY CARE HOSPITAL AT ONGOLE, PRAKASAM DISTRICT OF ANDHRA PRADESH. Srinivas, Gudi; Rao, Yarram Rajeswara; Samuel, Jyothula Joseph Report May 28, 2018 2258
HIV Preexposure Prophylaxis in the U.S. Military Services--2014-2016. Blaylock, Jason M.; Hakre, Shilpa; Okulicz, Jason F.; Garges, Eric; Wilson, Kerry; Lay, Jenny; Roska May 25, 2018 3139
IN VITRO EFFECT OF NEW ANTIBIOTICS AGAINST CLINICAL ISOLATES OF SALMONELLA PARATYPHI A. Report Apr 30, 2018 3704
A COMPARATIVE STUDY OF EFFICACY OF CLOTRIMAZOLE AND FLUCONAZOLE EAR DROPS IN OTOMYCOSIS. Prabhakaran, Preethi; Navin, Namasivaya; Srinivasan, Rajasekaran; Palanisamy, Thirunavukarasu; Kanag Report Apr 23, 2018 2371
Updated CDC Recommendations for Using Artemether-Lumefantrine for the Treatment of Uncomplicated Malaria in Pregnant Women in the United States. Ballard, Sarah-Blythe; Salinger, Allison; Arguin, Paul M.; Desai, Meghna; Tan, Kathrine R. Medical condition overview Apr 13, 2018 6604
Breckenridge Pharmaceutical wins final US FDA approval for Entecavir tablets (Baraclude) ANDA for hepatitis B infection. Mar 28, 2018 200
Breckenridge Pharmaceutical wins final US FDA approval for Entecavir tablets (Baraclude) ANDA for hepatitis B infection. Mar 28, 2018 196
Detection of Resistance, Susceptibility Pattern and Plasmid Profiling of Multi--Drug Resistant Pseudomonas aeruginosa Isolated from Burns Infections in Two Tertiary Baghdad Hospitals. Ibrahim, Aida H.; Sabbar, Amin A. Report Mar 1, 2018 3643
Grifols' HyperRAB 300 IU/ml wins US FDA approval for the treatment of rabies virus infection. Feb 7, 2018 254
Grifols' HyperRAB 300 IU/ml wins US FDA approval for the treatment of rabies virus infection. Feb 7, 2018 250
GC Pharma to Proceed with Phase 2/3 Clinical Trial of Recombinant Treatment for Prevention of Hepatitis B Infection After Liver Transplant. Jan 23, 2018 171
Common birth control drug ups risk of HIV in women. Jan 6, 2018 394
Chronic Hepatitis C Treatment with New Antiviral Agents/Ozlem Kandemir Chronic Hepatitis C Treatment with New Antiviral Agents. Kandemir, Ozlem Report Jan 1, 2018 10732
Effect of polymyxin B-containing regimens on renal function for the treatment of carbapenem-resistant Enterobacteriacea mediastinitis. Abboud, Cely Saad; Rao, Gauri G.; Souza, Ercilia E.; Zavascki, Alexandre P.; Kiffer, Carlos Jan 1, 2018 2581
Drug Hypersensitivity due to Azathioprine with Elevated Procalcitonin. Ahuja, Tania; Chung, Frank R.; Ruiz-Maya, Tania Jan 1, 2018 2186
Treatment of Chronic Hepatitis C Can Improve Glycemic Control in Patients with Type 2 Diabetes. Okuroglu, Nalan; Sertbas, Meltem; Ozdemir, Ali Jan 1, 2018 1294
Distribution of Microbes and Drug Susceptibility in Patients with Diabetic Foot Infections in Southwest China. Wu, Mingxia; Pan, Hang; Leng, Weiling; Lei, Xiaotian; Chen, Liu; Liang, Ziwen Jan 1, 2018 5285
Sofosbuvir Based Regimens in the Treatment of Chronic Hepatitis C with Compensated Liver Cirrhosis in Community Care Setting. Gayam, Vijay; Mandal, Amrendra Kumar; Khalid, Mazin; Mukhtar, Osama; Gill, Arshpal; Garlapati, Pavan Jan 1, 2018 5513
Applications of Click Chemistry in the Development of HIV Protease Inhibitors. Mudgal, Mukesh M.; Birudukota, Nagaraju; Doke, Mayur A. Jan 1, 2018 4082
Epstein-Barr Virus as a Promising Immunotherapeutic Target for Nasopharyngeal Carcinoma Treatment. Teow, Sin-Yeang; Yap, Hooi-Yeen; Peh, Suat-Cheng Jan 1, 2018 6723
A Systematic Review of the Efficacy and Safety of Fecal Microbiota Transplant for Clostridium difficile Infection in Immunocompromised Patients. Shogbesan, Oluwaseun; Poude, Dilli Ram; Victor, Samjeris; Jehangir, Asad; Fadahunsi, Opeyemi; Shogbe Report Jan 1, 2018 6194
The Cross-Sectional Evaluation of the Use of Artemisinin-Based Combination Therapy for Treatment of Malaria Infection at a Tertiary Hospital in Nigeria. Okoro, Roland Nnaemeka; Jamiu, Muslim Olakunle Jan 1, 2018 3717
UHPLC-Q-TOF MS-Based Metabolic Analysis for the Therapeutic Efficacy of "Xuebijing Injection" against Sepsis-Induced Acute Lung Injury. Shi, Xuan; Chen, Guannan; Wei, Juan; Feng, Di; Chen, Yuanli; Zhou, Huanping; Liu, Meiyun; Lv, Xin Jan 1, 2018 6455
Successful Antimicrobial Treatment of Phlegmonous Gastritis: A Case Report and Literature Review. Iqbal, Madiha; Saleem, Rabia; Ahmed, Salman; Jani, Prachi; Alvarez, Salvador; Tun, Han W. Jan 1, 2018 2883
Most new antibiotics in pipeline are short term solutions. Case study Nov 15, 2017 585
Vedanta Biosciences Receives Grant of Up To USD 5.4m from CARB-X for Development of Human Microbiome-Derived Treatment for Bacterial Infections. Nov 6, 2017 362
Why is the discovery of new antibiotics so difficult? Oct 31, 2017 708
Why is the discovery of new antibiotics so difficult? Oct 31, 2017 704
FDA Grants Orphan Drug Designation to Eiger for Lambda Interferon as Potential Treatment of Hepatitis Delta Virus Infection. Sep 6, 2017 300
Antiviral Medications, Part 2: HIV Antiretroviral Therapy. Penkalski, Melissa R.; Felicilda-Reynaldo, Rhea Faye D.; Patterson, Kathryn Sep 1, 2017 3311
AmpliPhi Biosciences Publishes Case Study of Successful Treatment of Antibiotic-Resistant Infection with Personalised Phage Therapy. Aug 22, 2017 265
FDA approves fluoroquinolone for skin and skin structure infections. Fulton, Denise Aug 1, 2017 196
Eiger wins US FDA's fast track designation for pegylated interferon lambda for the treatment of hepatitis delta virus infection. Jul 28, 2017 204
Eiger wins US FDA's fast track designation for pegylated interferon lambda for the treatment of hepatitis delta virus infection. Jul 28, 2017 200
Beyond antibiotics: Newer alternative approaches to chronic Lyme disease treatment. Strasheim, Connie Jul 1, 2017 3118
Safety and efficacy of a novel drug elores (ceftriaxone + sulbactam + disodium edetate) in the management of multi-drug resistant bacterial infections in tertiary care centers: a post-marketing surveillance study. Chaudhary, Manu; Mir, Mohd Amin; Ayub, Shiekh Gazalla Report Jul 1, 2017 6844
Antibiotics resistance: when the armamentarium gets to the verge of being empty. Balkhair, Abdullah Jul 1, 2017 1225
Study on post-operative infections with Teicoplanin prophylaxis in total knee arthroplasty. Reddy, B. Narendra; Babu, P. Anil Report May 15, 2017 2021
Pre-exposure prophylaxis for HIV prevention in East and Southern Africa. van der Wal, Ran; Loutfi, David May 1, 2017 2115
Bacteriophages, Natural Drugs to Combat Superbugs. Apr 19, 2017 1308
US FDA Approves New Indications for Harvoni, Sovaldi in Pediatric Chronic Hepatitis C Patients 12 Years and Older. Apr 10, 2017 404
Pfizer Inc unveils novel combination antibiotic Zavicefta for the treatment of Gram-negative bacterial infections in the UK and Germany. Mar 14, 2017 246
Pfizer Inc unveils novel combination antibiotic Zavicefta for the treatment of Gram-negative bacterial infections in the UK and Germany. Mar 14, 2017 242
Molecular evidence of drug resistance in asymptomatic malaria infections, Myanmar, 2015. Nyunt, Myat Htut; Shein, Thinzar; Zaw, Ni Ni; Han, Soe Soe; Muh, Fauzi; Lee, Seong-Kyun; Han, Jin-He Mar 1, 2017 2395
Successful treatment of human plague with oral ciprofloxacin. Apangu, Titus; Griffith, Kevin; Abaru, Janet; Candini, Gordian; Apio, Harriet; Okoth, Felix; Okello, Mar 1, 2017 1254
Initial results of efficacy and safety of Sofosbuvir among Pakistani Population: A real life trial Hepatitis Eradication Accuracy Trial of Sofosbuvir (HEATS). Feb 28, 2017 3220
Prevalence and Clinical Profile of Drug Eruptions among Antiretroviral Therapy-Exposed HIV Infected People in Yaounde, Cameroon. Kouotou, Emmanuel Armand; Nansseu, Jobert Richie; Ngono, Vanessa Nancy; Tatah, Sandra A.; Bissek, An Report Jan 1, 2017 3724
Effects of Honey on Oral Mucositis among Pediatric Cancer Patients Undergoing Chemo/Radiotherapy Treatment at King Abdulaziz University Hospital in Jeddah, Kingdom of Saudi Arabia. Jaouni, Soad K. Al; Muhayawi, Mohammad S. Al; Hussein, Abear; Elfiki, Iman; Raddadi, Rajaa Al-; Muha Clinical report Jan 1, 2017 5665
Effectiveness of Chinese Herbal Medicine Combined with Antibiotics for Extensively Drug-Resistant Enterobacteria and Nonfermentative Bacteria Infection: Real-Life Experience in a Retrospective Cohort. Cai, Yangping; Zhang, Qing; Fu, Yuefeng; Li, Li; Zhao, Ning; Lu, Aiping; Liu, Qingquan; Jiang, Miao Report Jan 1, 2017 6368
Optimal Control Model of Tumor Treatment with Oncolytic Virus and MEK Inhibitor. Su, Yongmei; Jia, Chen; Chen, Ying Report Jan 1, 2017 4030
Poxel announces Phase 1 Initiation of EYP001 by ENYO Pharma SA for the treatment of chronic hepatitis b virus infection. Dec 20, 2016 258
Poxel announces Phase 1 Initiation of EYP001 by ENYO Pharma SA for the treatment of chronic hepatitis b virus infection. Dec 20, 2016 254
Resistance to direct antiviral agents for hepatitis C virus infection. Impact on clinical practice? Perez, Ana Belen; Garcia, Federico Dec 1, 2016 800
Treatment of hepatitis C virus genotype 3 infection with direct-acting antiviral agents. Zanaga, L.P.; Miotto, N.; Mendes, L.C.; Stucchi, R.S.B.; Vigani, A.G. Report Nov 1, 2016 5810
Proper treatment of herpes zoster 'a work in progress'. Brunk, Doug Disease/Disorder overview Oct 1, 2016 1019
Proper treatment of herpes zoster is 'a work in progress'. Brunk, Doug Disease/Disorder overview Sep 15, 2016 1028
New HIV antiretroviral guidelines embrace PrEP, early ART. Pizzi, Richard Sep 1, 2016 387
Treating gram-negative bacterial infections. Sep 1, 2016 177
SCYNEXIS passes US FDA orphan drug designation for SCY-078 for invasive aspergillus infections. Aug 25, 2016 321
SCYNEXIS passes US FDA orphan drug designation for SCY-078 for invasive aspergillus infections. Aug 25, 2016 317
Predictors of early treatment discontinuation and severe anemia in a Brazilian cohort of hepatitis C patients treated with first-generation protease inhibitors. Miotto, N.; Mendes, L.C.; Zanaga, L.P.; Goncales, E.S.L.; Lazarini, M.S.K.; Pedro, M.N.; Goncales, F Report Jul 1, 2016 6930
Allergan wins US FDA approval for sNDA for updated label for AVYCAZ for treating complicated intra-abdominal infections (cIAI). Jun 24, 2016 276
Allergan wins US FDA approval for sNDA for updated label for AVYCAZ for treating complicated intra-abdominal infections (cIAI). Jun 24, 2016 272
Topical Antibiotic Pharmaceuticals Market Growth and Segments, 2016-2026. Jun 3, 2016 779
Hepatitis-C virus infection among injecting drug users in Lahore, Pakistan: A cross sectional study. Report Apr 30, 2016 3348
Smoking, viral infection reduce efficacy of lung medications. Apr 12, 2016 243
Chronic hepatitis C: treatment, complications, and long-term outcomes in a population of Latino Veterans. Santiago-Rolon, Amarilys; Purcell, Dagmary; Grigg, Nicole; Toro, Doris H. Report Mar 1, 2016 3653
Merck's ZEPATIER approved for HCV. Mar 1, 2016 184
Antiviral treatment of hepatitis C in Serbian prison setting: medical treatment outcomes and patients' adherence/Antivirusno lecenje hepatitisa C u zatvorskim uslovima u Srbji: ishod lecenjai adherencija pacijenata. Babic, Jasmina Simonovic; Bojovic, Ksenija; Delic, Dragan; Katanic, Natasa; Mitrovic, Nikola; Malini Mar 1, 2016 4364
Understanding the CDC's updated HIV test protocol. Kapler, Robert Feb 1, 2016 3899
Merck passes US FDA's priority review approval of ZEPATIER (elbasvir and grazoprevir) for treating Chronic Hepatitis C Virus Genotype 1 or 4 Infection. Jan 29, 2016 317
Merck passes US FDA's priority review approval of ZEPATIER (elbasvir and grazoprevir) for treating Chronic Hepatitis C Virus Genotype 1 or 4 Infection. Jan 29, 2016 313
Increased risk for ESBL-producing bacteria from co-administration of loperamide and antimicrobial drugs for travelers' diarrhea. Kantele, Anu; Mero, Sointu; Kirveskari, Juha; Laaveri, Tinja Jan 1, 2016 2859
Ertapenem articulating spacer for the treatment of polymicrobial total knee arthroplasty infection. Radoicic, Dragan; Milanovic, Milomir; Marinkovic, Jugoslav; Radoicic, Danica Report Jan 1, 2016 3583
Volatiles from Subtropical Convolvulaceae That Interfere with Bacterial Cell-to-Cell Communication as Potential Antipathogenic Drugs. Luciardi, Maria C.; Hernandez, Maria V. Perez; Muruaga, Nora; Bardon, Alicia; Arena, Mario E.; Carta Jan 1, 2016 5206
Adolescent HIV treatment issues in South Africa. Dawood, H. Report Nov 1, 2015 2243
Genetic predictors of the response to the treatment of hepatitis C virus infection. Dzekova-Vidimliski, Pavlina; Nikolov, Igor G.; Matevska-Geshkovska, Nadica; Boyanova, Yana; Nikolova Nov 1, 2015 3614
Fungus: new treatment options for toenail onychomycosis and tinea pedis. Ceilley, Roger I. Sep 1, 2015 2474
Understanding onychomycosis treatment: mechanisms of action and formulation. Jellinek, Nathaniel J.; Rich, Phoebe; Pariser, David M. Drug overview Aug 1, 2015 2468
Recognizing guttate psoriasis and initiating appropriate treatment. Vence, Lacey; Schmitt, Amanda; Meadows, Charles E.; Gress, Todd Report Jul 1, 2015 1490
Increases in Hepatitis C virus infection related to injection drug use among persons aged <30 years --Kentucky, Tennessee, Virginia, and West Virginia, 2006-2012. Zibbell, Jon E.; Iqbal, Kashif; Patel, Rajiv C.; Suryaprasad, Anil; Sanders, Kathy J.; Moore-Moravia May 8, 2015 3125
Recommendations for the treatment and prevention of malaria: update for the 2015 season in South Africa. Blumberg, L.H. Report Mar 1, 2015 2453
Treatment of Ebola virus infection with antibodies from reconvalescent donors. Kreil, Thomas R. Mar 1, 2015 1954
Innovation for Community Health: Antibiotic Activity of Moringa oleifera Lam. Leaves Extract. Reyno, Leonila S.; Paulican, Apolinar T.; Deoquino, Ed Bimbo; Win, Khin Khin; Lao, Sengpor Report Dec 1, 2014 2577
The new hepatitis C paradigm: a synergy of diagnostics and drug therapy. Cloherty, Gavin Sep 1, 2014 1372
Efficacy of azithromycin in un-complicated enteric fever. A study from rural north India. Kapoor, Satya Kiran; Tiwari, Pawan; Tiwari, Madhu; Yadav, Yogesh Report Sep 1, 2014 2439
The Medicines Company passes the US FDA approval for ORBACTIV for injection for treating acute bacterial skin and skin structure infections (ABSSSIs), with expected launch in 2H/2014. Aug 7, 2014 204
The Medicines Company passes the US FDA approval for ORBACTIV for injection for treating acute bacterial skin and skin structure infections (ABSSSIs), with expected launch in 2H/2014. Aug 7, 2014 200
HIV post exposure prophylaxis awareness among the nursing staff. Aswar, Nandkeshav R.; Barure, Balaji S.; Inamdar, I.F.; Tambe, Saleem H.; Mohammed, Ubaidulla; Akank May 26, 2014 1738
Cellceutix to formulate the Brilacidin drug for ophthalmic and otitis infections at Dr Reddy's Laboratories. Feb 25, 2014 235
Cellceutix to formulate the Brilacidin drug for ophthalmic and otitis infections at Dr Reddy's Laboratories. Feb 25, 2014 231
Potential treatment for deadly bacterial infections discovered. Jan 19, 2014 373
Chemicals kill all stages of malaria: experimental drugs could treat active and dormant infections. Mole, Beth Dec 28, 2013 333
Merck wins US FDA's priority review for NDA for IV formulation of NOXAFIL for prophylaxis of invasive Aspergillus and Candida infections. Nov 19, 2013 209
Merck wins US FDA's priority review for NDA for IV formulation of NOXAFIL for prophylaxis of invasive Aspergillus and Candida infections. Nov 19, 2013 195
Bristol Myers Squibb submits NDA to Japanese authorities for first all-oral, interferon-free and ribavirin-free treatment regimen for chronic hepatitis c infection. Nov 4, 2013 199
Bristol Myers Squibb submits NDA to Japanese authorities for first all-oral, interferon-free and ribavirin-free treatment regimen for chronic hepatitis c infection. Nov 4, 2013 195
Merck announces receipt of Breakthrough Therapy designation for MK-5172/MK-8742 for the treatment of Chronic Hepatitis C Virus (HCV) infection. Oct 23, 2013 222
Medivir announces approval of Simeprevir in Japan for the treatment of genotype 1 chronic hepatitis C infection. Sep 27, 2013 129
Medivir announces approval of Simeprevir in Japan for the treatment of genotype 1 chronic hepatitis C infection. Sep 27, 2013 125
Tetraphase Pharmaceuticals Inc announces dosing of first patient with eravacycline in Phase 3 study for complicated intra-abdominal infections. Sep 4, 2013 235
Current and emerging options in the treatment of onychomycosis. Elewshi, Boni; Pariser, David; Rich, Phoebe; Scher, Richard K. Sep 1, 2013 3428
Current and emerging options in the treatment of onychomycosis. Elewski, Boni; Pariser, David; Rich, Phoebe; Scher, Richard K. Sep 1, 2013 3425
Investigational drug available directly from CDC for the treatment of infections with free-living Amebae. Cope, Jennifer R. Aug 23, 2013 474
Locations and reasons for initial testing for hepatitis C infection--chronic hepatitis cohort study, United States, 2006-2010. Boscarino, Joseph A.; Gordon, Stuart C.; Rupp, Loralee B.; Schmidt, Mark A.; Vijayedeva, Vinutha; Mo Aug 16, 2013 2990
Malaria Vaccine Found Safe and Protective. Aug 10, 2013 733
Investigational malaria vaccine could rid humankind of deadly disease. Aug 9, 2013 526
Pre-exposure prophylaxis for HIV prevention: ready for prime time in South Africa? Eakle, R.; Venter, W.D.F.; Rees, H. Clinical report Aug 1, 2013 2757
Two antibiotics show new gonorrhea efficacy. Zoler, Mitchel L. Aug 1, 2013 743
Will an arthritis drug end urinary infections? Jul 1, 2013 145
ERUPTION OF ORAL LICHEN PLANUS AFTER INTERFERON THERAPY FOR HEPATITIS C INFECTION: CASE REPORT. Jun 21, 2013 2585
PharmaPoint: Pediatric Respiratory Syncytial Virus (RSV) Prophylactics - New Report. Jun 6, 2013 556
U.S. women want answers on PrEP. Reddy, Allyson May 1, 2013 1279
Longer HIV treatment linked to lower AIDS cancer rate but has differing effects on non-AIDS cancers. Mar 1, 2013 1428
HIV drug 'may help defuse deadly staph infections'. Dec 15, 2012 633
Treatment strategies for atopic dermatitis: optimizing the available therapeutic options. Paller, Amy S.; Simpson, Eric L.; Eichenfield, Lawrence F.; Ellis, Charles N.; Mancini, Anthony J. Oct 1, 2012 6190
A*STAR Scientists: Earlier Treatment for Young Patients With Chronic Hepatitis B May Be More Effective in Clearing Virus. Sep 6, 2012 926
Protease inhibitors and stomach acid drugs linked to fractures in HIV+ veterans. Sep 1, 2012 1443
Effectiveness of cognitive behavioral therapy a long with conventional treatment in asthma patients compared with solely conventional therapy. Jamalimotlagh, Maryam; Rezaei, Omid; Fata, Ladan; Jamaati, Hamidreza; Masafi, Saeede Report Sep 1, 2012 4102
The efficacy of Pelargonium sidoides in the treatment of upper respiratory tract infections in children with transient hypogammaglobulinemia of infancy. Patiroglu, Turkan; Tunc, Aydin; Gungor, Hatice Eke; Unal, Ekrem Clinical report Aug 15, 2012 3675
Mylan Inc unveils generic Sporanox capsules for fungal infections in the lungs. Jul 30, 2012 169
Four Ways to Reduce Hepatitis Infection among Drug Users. Jul 23, 2012 467
Supply of (a) H5 N1 vaccines of local production and race, also (b) sovereign veterinary medicines including a compound to treat fashiola infections, another to combat stomach worms and an insecticide to spray on animals. May 17, 2012 154
Pernix Therapeutics Holdings Inc unveils US FDA approved Omeclamox-Pak, eradicating Helicobacter pylori bacteria infection in just 10 days. May 16, 2012 167
Therapeutic effectiveness of biosimilar standard interferon versus pegylated interferon for chronic hepatitis C genotypes 2 or 3. Vigani, Aline Gonzalez; Goncales, Eduardo Sellan; Pavan, Maria Helena Postal; Genari, Flavia; Tozzo, May 1, 2012 2921
Antiretroviral treatment as prevention: considerations for nursing practice. Bennett, Juliet Report Mar 22, 2012 2601
In vitro study of the effect of a probiotic bacterium Lactobacillus rhamnosus against herpes simplex virus type 1. Khani, Soghra; Motamedifar, Mohammad; Golmoghaddam, Hossein; Hosseini, Hamideh Mahmoodzadeh; Hashemi Report Mar 1, 2012 5246
Guideline summary: appropriate use of tigecycline. Brink, A.J.; Bizos, D.; Boffard, K.D.; Feldman, C.; Grolman, D.C.; Pretorius, J.; Richards, G.A.; St Feb 1, 2012 1296
Prior glucocorticoids raise infection risk in RA. McCall, Becky Feb 1, 2012 624
Fluoroquinolones: risks and benefits. Jackson, Mary Anne Report Dec 1, 2011 766
Assess risk/benefits for fluoroquinolones. Jackson, Mary Anne Nov 1, 2011 774
Risk of coronary artery disease in individuals infected with human immunodeficiency virus. Vilela, Felippe Dantas; de Lorenzo, Andrea Rocha; Tura, Bernardo Rangel; Ferraiuoli, Giovanna Ianini Nov 1, 2011 5444
Simultaneous detection of hepatitis B virus genotypes and mutations associated with resistance to lamivudine, adefovir, and telbivudine by the polymerase chain reaction-ligase detection reaction. Wang, Yong-Zhong; Xiao, Jun-Hua; Liu, Long-Gen; Ye, Chun-Yan; Shen, Hong-Yu; Xu, Tian-Min; Zhu, Ke-Z Nov 1, 2011 4190
New Delhi Call to Action on Preserving the Power of Antibiotics. Oct 4, 2011 1056
FDA issues tentative approval for new lamivudine and zidovudine tablet for treatment of HIV-1 infection. Sep 23, 2011 164
Helicobacter pylori infection: a review of current scientific research on the efficacy or potential of herbal medicine for the treatment of H. pylori infection of the gastric mucosa. Williams, Lee Report Sep 22, 2011 5465
Pharmasseta[euro](tm)s PSI-938 receives fast track designation from the FDA for the treatment of chronic Hepatitis C infection. Aug 25, 2011 233
[beta]-lactams vs. [beta]-lactamases--recent evolution of concurrent occurrence of multiple bla genes including [bla.sub.CTX-M] and [bla.sub.ampC]: an Indian scenario. Shahid, Mohd. Report Aug 1, 2011 10130
HIV prophylaxis slashed heterosexual infection. Wendling, Patrice Aug 1, 2011 957
Atox Bio completes Phase I study of bacterial infections and sepsis treatment AB103. May 13, 2011 251
Sugar helps medicine's battle against chronic bacterial infections. May 12, 2011 183
Infection alerts. Brief article May 1, 2011 183
Candida species isolated from the vaginal mucosa of HIV-infected women in Salvador, Bahia, Brazil. Oliveira, Paula Matos; Mascarenhas, Rita Elizabeth; Lacroix, Claire; Ferrer, Suzana Ramos; Oliveira, May 1, 2011 3288
FDA committee recommends approval of Merck's VICTRELIS in HCV genotype 1 infection. Apr 28, 2011 186
Mercka[euro](tm)s VICTRELIS unanimously recommended for approval by FDA advisory committee for treatment of chronic HCV Genotype 1 Infection. Apr 28, 2011 240
Hi-Tech Pharmacal Co Inc reports receipt of tentative FDA approval of levofloxacin oral solution for infections. Apr 8, 2011 199
Ear infections in Karachi: The frequency and antibiotic resistance of bacterial isolates. Clinical report Mar 31, 2011 3212
Difficulties with interferon treatment in former intravenous drug users. Gazdag, Gabor; Horvath, Gergely; Szabo, Olga; Ungvari, Gabor S. Mar 1, 2011 2144
FDA grants tentative approval of Cipla's abacavir sulfate in HIV-1 infection. Feb 18, 2011 170
Drugs, pregnancy, and lactation: treatment of genital herpes simplex. Briggs, Gerald G. Feb 1, 2011 961
HIV-1 drug resistance genotypic profiles in children with undetectable plasma viremia during antiretroviral therapy. de Angelis, Daniela Souza Araujo; Tateno, Adriana Fumie; Diaz, Ricardo Sobhie; Succi, Regina Celia d Jan 1, 2011 3820
HIV drugs offer barrier to virus: antiretrovirals limit infection rate among men at high risk. Seppa, Nathan Dec 18, 2010 330
Bactrim. Simpson, Nova Drug overview Nov 1, 2010 522
Sulfadoxine/pyrimethamine intermittent preventive treatment for malaria during pregnancy. Deloron, Philippe; Bertin, Gwladys; Briand, Valerie; Massougbodji, Achille; Cot, Michel Nov 1, 2010 3852
Treatment of methicillin-resistant Staphylococcus aureus in Latin America. Luna, Carlos M.; Rodriguez-Noriega, Eduardo; Bavestrello, Luis; Gotuzzo, Eduardo Nov 1, 2010 6470
HIV drug treatment doesn't reduce risk of partner infection. Oct 1, 2010 343
Antiviral gel promising against HIV: topical treatment cuts infection rates in South African women. Dickey, Gwyneth Report Aug 14, 2010 406
New guidelines endorse earlier HIV treatment: treatment should be considered in asymptomatic patients with a CD4 cell count above 500/mcL. Zoler, Mitchel L. Aug 1, 2010 1306
AIDS gel medicine helps reduce infections. Jul 19, 2010 309
Febrile neutropenia in childhood cancer: improved outcomes in childhood cancer have been achieved largely through more intensive and toxic treatment regimens. Reynders, David Jul 1, 2010 2231
Antibiotic therapy of surgical infections. Richards, G.A. Report Jul 1, 2010 3323
Prophylaxis following occupational exposure to HIV. Manika; Shashikant, M.C.; Shailaja, S. Report Jul 1, 2010 3056
Blood-thinning drug can stop malaria infection. Jun 2, 2010 263
Early antibiotic treatment in a child with PANDAS: a case report/PANDAS tanili bir cocukta erken antibiyotik tedavisi bir olgu sunumu. Ayaydin, Hamza; Abali, Osman Case study Jun 1, 2010 1185
Dynavax drug candidate against HCV infection shows positive results in studies. Clinical report Jan 26, 2010 202
New discovery may lead to treatment for genital herpes infection. Jan 23, 2010 246
Breast cancer drug effective against life-threatening fungal infections too. Jul 21, 2009 423
Infections emerge long after cancer's treatment. Jancin, Bruce Jun 1, 2009 250
Popular cancer drug rituximab may lead to oft-fatal viral brain infection. May 19, 2009 417
A randomized controlled trial to assess the safety and efficacy of silymarin on symptoms, signs and biomarkers of acute hepatitis. El-Kamary, Samer S.; Shardell, Michelle D.; Abdel-Hamid, Mohamed; Ismail, Soheir; El-Ateek, Mohamed; Report May 1, 2009 6081
A comparative study of single-dose treatment of chancroid using thiamphenicol versus azithromycin. Walter, B., Jr.; Di Chiacchio, Nilton G.; Romiti, Ricardo; Criado, Paulo R.; Ferreira Velho, Paulo E May 1, 2009 2069
Starting infants on antiretroviral therapy. Clayden, Polly Mar 22, 2009 3588
Infection is one of the commonest causes of death in burn patients, particularly those with extensive damage. Rode, H.; Vale, I.Do; Millar, A.J.W. Report Jan 1, 2009 2902
Antimicrobial drug use and resistance in Europe. van de Sande-Bruinsma, Nienke; Grundmann, Hajo; Verloo, Didier; Tiemersma, Edine; Monen, Jos; Goosse Clinical report Nov 1, 2008 6303
Ceftobiprole rivals vancomycin-based combination for skin infections. Dixon, Bruce K. Mar 15, 2008 344
NEW DRUG FIGHTS BACTERIAL INFECTIONS IN NOVEL WAY. Feb 1, 2008 1062
Impact of resistant pathogens on the treatment of otitis. Coates, Harvey Nov 1, 2007 2807
ViroPharma granted fast track status by FDA for new hepatitis C virus infection treatment. Jul 1, 2007 185
Preventive antibiotics out for most heart patients. Splete, Heidi May 15, 2007 591
Flags cited for treating complex cases of acute otitis media. Boschert, Sherry Jan 1, 2007 381
Treating ear infections. Sagall, Richard J. Brief article Jan 1, 2007 236
Use fluoroquinolones judiciously. Pichichero, Michael E. Oct 1, 2006 835

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |